Sep 18, 2017 11:00 am UTC| Business
Pluristem’s Ongoing Phase III CLI trial has been selected for accelerated approval pathways in both the U.S. and EuropeFast Track Designation allows for expedited review of drugs to treat serious conditions with unmet...
RedHill Biopharma to Present at the Cantor Fitzgerald Global Healthcare Conference
Sep 18, 2017 11:00 am UTC| Business
TEL-AVIV, Israel and RALEIGH, N.C., Sept. 18, 2017 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late...
Sep 18, 2017 11:00 am UTC| Business
Holders of class B common stock (other than our Chief Executive Officer, Michael Hays) to receive $53.44 per share in cashClass B common stock to be delistedClass A common stock to be sole publicly traded security of the...
Kamada Announces CFO Transition
Sep 18, 2017 11:00 am UTC| Business
Gil Efron, Deputy CEO and CFO, to Depart Kamada at End of Year; Chaime Orlev to Assume CFO Duties REHOVOT, Israel, Sept. 18, 2017 -- Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics...
Aehr Test Systems to Announce First Quarter Fiscal 2018 Financial Results on September 28, 2017
Sep 18, 2017 11:00 am UTC| Business
FREMONT, Calif., Sept. 18, 2017 -- Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced that it will report financial results for its first quarter of fiscal...
Sep 18, 2017 11:00 am UTC| Business
- Lefamulin met all primary FDA and EMA endpoints with a favorable tolerability profile - - Conference call and webcast today at 8:30 a.m. EDT to review results - DUBLIN, Ireland and KING OF PRUSSIA, Pa., Sept. 18,...
Sep 18, 2017 11:00 am UTC| Business
VICTORIA, British Columbia, Sept. 18, 2017 -- Emerald Health Therapeutics Inc. (Therapeutics) (TSX-V:EMH) (OCTQX:EMHTF) has released Island Mist, its proprietary high cannabidiol (CBD) and high CBD to THC ratio dried...